ARANESP for Nephrogenic anaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 1,740 adverse event reports in the FDA FAERS database where ARANESP was used for Nephrogenic anaemia.
Most Reported Side Effects for ARANESP
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 2,018 | 65.7% | 2,018 | 50 |
| Investigation | 403 | 13.1% | 28 | 401 |
| Hospitalisation | 289 | 9.4% | 11 | 288 |
| Dialysis | 35 | 1.1% | 0 | 9 |
| Haemoglobin decreased | 32 | 1.0% | 1 | 11 |
| Aplasia pure red cell | 26 | 0.9% | 1 | 14 |
| Transfusion | 18 | 0.6% | 1 | 11 |
| Dyspnoea | 17 | 0.6% | 2 | 10 |
| Haemoglobin abnormal | 17 | 0.6% | 1 | 7 |
| Anaemia | 16 | 0.5% | 2 | 8 |
| Fatigue | 16 | 0.5% | 1 | 10 |
| Pneumonia | 15 | 0.5% | 4 | 14 |
| Drug ineffective | 14 | 0.5% | 0 | 4 |
| Asthenia | 13 | 0.4% | 2 | 9 |
| Malaise | 13 | 0.4% | 1 | 8 |
Other Indications for ARANESP
Anaemia (747)
Product used for unknown indication (347)
Myelodysplastic syndrome (166)
Renal failure chronic (56)
Haemoglobin decreased (5)
Other Drugs Used for Nephrogenic anaemia
DARBEPOETIN ALFA (5,332)
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA (2,331)
DAPRODUSTAT (859)
ERYTHROPOIETIN (750)
PEGZEREPOETIN ALFA (325)
EPOETIN ALFA-EPBX (169)
VADADUSTAT (140)
MIRCERA (100)
ENARODUSTAT (66)
ROXADUSTAT (57)